Patents by Inventor Hester Catharina VAN DIEPEN

Hester Catharina VAN DIEPEN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Antisense oligonucleotides for the treatment of eye disease
    Patent number: 11479771
    Abstract: The invention relates to the fields of medicine and immunology. In particular, it relates to novel antisense oligonucleotides (AONs) that may be used in the treatment, prevention and/or delay of Usher syndrome type II and/or USH2A-associated non syndromic retina degeneration.
    Type: Grant
    Filed: February 7, 2020
    Date of Patent: October 25, 2022
    Assignee: ProQR Therapeutics II B.V.
    Inventors: Hester Catharina Van Diepen, Janne Juha Turunen, Hee Lam Chan
  • OLIGONUCLEOTIDES TO TREAT EYE DISEASE
    Publication number: 20210401871
    Abstract: The invention relates to the fields of medicine and immunology. In particular, it relates to novel antisense oligonucleotides that may be used in the treatment, prevention and/or delay of Usher Syndrome type II and/or USH2A-associated non syndromic retina degeneration, especially by skipping a pseudo exon (PE40) between exon 40 and 41 in the human USH2A gene.
    Type: Application
    Filed: September 15, 2021
    Publication date: December 30, 2021
    Inventors: Hester Catharina Van Diepen, Hee Lam Chan, Janne Juha Turunen
  • Oligonucleotides to treat eye disease
    Patent number: 11123360
    Abstract: The invention relates to the fields of medicine and immunology. In particular, it relates to novel antisense oligonucleotides that may be used in the treatment, prevention and/or delay of Usher Syndrome type II and/or USH2A-associated non syndromic retina degeneration, especially by skipping a pseudo exon (PE40) between exon 40 and 41 in the human USH2Agene.
    Type: Grant
    Filed: March 6, 2020
    Date of Patent: September 21, 2021
    Assignee: ProQR Therapeutics II B.V.
    Inventors: Hester Catharina Van Diepen, Hee Lam Chan, Janne Juha Turunen
  • OLIGONUCLEOTIDES TO TREAT EYE DISEASE
    Publication number: 20200237802
    Abstract: The invention relates to the fields of medicine and immunology. In particular, it relates to novel antisense oligonucleotides that may be used in the treatment, prevention and/or delay of Usher Syndrome type II and/or USH2A-associated non syndromic retina degeneration, especially by skipping a pseudo exon (PE40) between exon 40 and 41 in the human USH2Agene.
    Type: Application
    Filed: March 6, 2020
    Publication date: July 30, 2020
    Inventors: Hester Catharina Van Diepen, Hee Lam Chan, Janne Juha Turunen
  • ANTISENSE OLIGONUCLEOTIDES FOR THE TREATMENT OF EYE DISEASE
    Publication number: 20200181616
    Abstract: The invention relates to the fields of medicine and immunology. In particular, it relates to novel antisense oligonucleotides (AONs) that may be used in the treatment, prevention and/or delay of Usher syndrome type II and/or USH2A-associated non syndromic retina degeneration.
    Type: Application
    Filed: February 7, 2020
    Publication date: June 11, 2020
    Inventors: Hester Catharina Van Diepen, Janne Juha Turunen, Hee Lam Chan
  • Oligonucleotides to treat eye disease
    Patent number: 10617707
    Abstract: The invention relates to the fields of medicine and immunology. In particular, it relates to novel antisense oligonucleotides that may be used in the treatment, prevention and/or delay of Usher Syndrome type II and/or USH2A-associated non syndromic retina degeneration, especially by skipping a pseudo exon (PE40) between exon 40 and 41 in the human USH2A gene.
    Type: Grant
    Filed: April 25, 2017
    Date of Patent: April 14, 2020
    Assignee: ProQR Therapeutics II B.V.
    Inventors: Hester Catharina Van Diepen, Hee Lam Chan, Janne Juha Turunen
  • Antisense oligonucleotides for the treatment of eye disease
    Patent number: 10612025
    Abstract: The invention relates to the fields of medicine and immunology. In particular, it relates to novel antisense oligonucleotides (AONs) that may be used in the treatment, prevention and/or delay of Usher syndrome type II and/or USH2A-associated non syndromic retina degeneration.
    Type: Grant
    Filed: September 22, 2017
    Date of Patent: April 7, 2020
    Assignee: ProQR Therapeutics II B.V.
    Inventors: Hester Catharina Van Diepen, Janne Juha Turunen, Hee Lam Chan
  • OLIGONUCLEOTIDES TO TREAT EYE DISEASE
    Publication number: 20190381089
    Abstract: The invention relates to the fields of medicine and immunology. In particular, it relates to novel antisense oligonucleotides that may be used in the treatment, prevention and/or delay of Usher Syndrome type II and/or USH2A-associated non syndromic retina degeneration, especially by skipping a pseudo exon (PE40) between exon 40 and 41 in the human USH2A gene.
    Type: Application
    Filed: April 25, 2017
    Publication date: December 19, 2019
    Inventors: Hester Catharina VAN DIEPEN, Hee Lam CHAN, Janne Juha TURUNEN
  • ANTISENSE OLIGONUCLEOTIDES FOR THE TREATMENT OF EYE DISEASE
    Publication number: 20190256847
    Abstract: The invention relates to the fields of medicine and immunology. In particular, it relates to novel antisense oligonucleotides (AONs) that may be used in the treatment, prevention and/or delay of Usher syndrome type II and/or USH2A-associated non syndromic retina degeneration.
    Type: Application
    Filed: September 22, 2017
    Publication date: August 22, 2019
    Inventors: Hester Catharina Van Diepen, Janne Juha Turunen, Hee Lam Chan